EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Pulsenmore Ltd. (PLSM) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Pulsenmore Ltd. $3.20, price $2.44, upside +31.2%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN IL0011767006

PL Pulsenmore Ltd. logo Thin data Sep 24, 2026

Pulsenmore Ltd.

PLSM · US

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value $3.20 · Undervalued (+31%)
!Quality 60/100
!Expensive Growth (revenue 3y +55.8 %/yr)
!Loss-making · -39.6% net margin (TTM)
!negative free cash flow
!Mixed vs. peers (4/8)
!Narrow moat 10/100
!Evidence only low, so the estimate is less certain
Watch Pulsenmore Ltd. Ordinary Shares for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$2,151 $2.22 Fair Value $3.20 Dec 2025 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.

How to read this chart

9‑month range $2.22 – $2,151 · fair‑value band $2.11 – $4.00 · the $2.44 price screens below the $3.20 fair value. As of Sep 24, 2026.

Follow Pulsenmore Ltd. Ordinary Shares in your weekly email

Every Wednesday you see whether Pulsenmore Ltd. Ordinary Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.

Stock analysis

Pulsenmore Ltd. Ordinary Shares (PLSM) currently trades at $2.44, while our model-based Fair Value estimate is $3.20, implying the stock looks roughly 23.8% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $2.11 (bear) to $4.00 (bull), the price of $2.44 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Pulsenmore Ltd. Ordinary Shares reported revenue of 40.0M ILS in FY2025 versus 1.6M ILS in FY2021, a compound +124.5%/yr. Reported net income was −15.9M ILS in FY2025.

Key figures

Market cap $15.7M · EPS (TTM) $−0.8400 · Net margin −39.6% · Return on equity −17.6% · Return on assets (EBIT) −21.1% · Revenue growth (YoY) +578% · Free cash flow −33.0M ILS · Net cash 20.0M ILS.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at 31%, PLSM screens cheaper than that median.

Fair Value models

Bear $2.11 Fair Value $3.20 Bull $4.00
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $6.39 $8.56 $12.78 51
All 1 models by family
Asset-Based
NCAV (Graham) $6.39 $8.56 $12.78 51

Open the full fair value analysis →

Notify me when PLSM reaches fair value

Put PLSM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 60/100

Of which business quality 58 · Market factors (momentum, volatility) 15

Profitability 16
Margins and returns on capital today
Quality Growth 100
Are margins and returns improving?
Cashflow 33
Earnings quality: real cash, not paper profit
Fin. Strength 68
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 69
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+315.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+55.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,390.2% (2021) → −30.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch PLSM, get fair value alerts →

Compare Pulsenmore Ltd. Ordinary Shares with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 361 stocks

Beats the industry median on 4/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside +31% · Top 25%
Profitability
Return on assets −6% · Below median
Net margin (TTM) −40% · Bottom 25%
Operating margin (TTM) 0% · Below median
Growth and dividend
Revenue growth 578% · Top 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 0.19× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)75 · sector 11
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)0 · sector 8
HEALTH (low debt)0 · sector 97
DIVIDEND (yield)0 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $103.69 $74.79 −28%
Stryker Corporation SYK $275.09 $302.60 +10%
Medtronic plc MDT $90.77 $65.57 −28%
Boston Scientific Corporation BSX $44.92 $49.41 +10%
Edwards Lifesciences Corporation EW $88.78 $82.04 −8%
Siemens Healthineers AG SHL €37.43 €35.22 −6%
DexCom, Inc DXCM $89.53 $98.48 +10%
GE HealthCare Technologies Inc GEHC $66.27 $69.62 +5%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥156.68 ¥172.35 +10%
Koninklijke Philips N.V PHIA €21.85 €15.32 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Pulsenmore Ltd. Ordinary Shares Fair Value". https://www.fairvalue-calculator.com/stock/PLSM

Frequently asked questions

Is Pulsenmore Ltd. (PLSM) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $3.20 versus a price of $2.44, about +31% upside (undervalued).
What is the fair value of PLSM?
Our model-based fair value for Pulsenmore Ltd. Ordinary Shares is $3.20 (as of Sep 24, 2026), built from audited fundamentals. The current price: $2.44.
What is the quality score of PLSM?
Pulsenmore Ltd. Ordinary Shares has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Pulsenmore Ltd. (PLSM)?
Our model-based price target is the fair value of $3.20 (as of Sep 24, 2026) from 1 valuation models. Cautious scenario $2.11, optimistic scenario $4.00. It is a calculation from audited fundamentals, not an analyst target.
What is the Pulsenmore Ltd. Ordinary Shares stock forecast for 2026?
Our models put fair value at $3.20, about +31% upside versus a price of $2.44 (undervalued). Cautious scenario $2.11, optimistic scenario $4.00. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Pulsenmore Ltd. (PLSM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Pulsenmore Ltd. Ordinary Shares it is $3.20 per share (as of Sep 24, 2026), against a price of $2.44. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Pulsenmore Ltd. Ordinary Shares stock overvalued or undervalued in 2026?
As of Sep 24, 2026, PLSM trades below its calculated fair value: price $2.44, fair value $3.20, a gap of about +31% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PLSM?
No. The price is what the market pays today ($2.44); the fair value is what the company's own numbers justify ($3.20). For Pulsenmore Ltd. Ordinary Shares the two are $0.7600 per share apart. That gap is exactly why we show both numbers side by side.
How much is Pulsenmore Ltd. Ordinary Shares worth?
The market values Pulsenmore Ltd. Ordinary Shares at about $15.7M (market capitalisation, as of Sep 24, 2026). Per share that is $2.44; our models calculate a fair value of $3.20 per share.
What do the bullish and bearish scenarios say about PLSM?
Our models span a range for Pulsenmore Ltd. Ordinary Shares: cautious scenario $2.11, base $3.20, optimistic $4.00 per share (as of Sep 24, 2026, price $2.44). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Pulsenmore Ltd. (PLSM)?
Balance-sheet figures for Pulsenmore Ltd. Ordinary Shares (as of Sep 24, 2026): return on equity −17.6%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
Which stocks are comparable to Pulsenmore Ltd. Ordinary Shares?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Pulsenmore Ltd. Ordinary Shares stock attractive at the current price?
The data as of Sep 24, 2026: price $2.44, calculated fair value $3.20 (+31%), Quality Score 60/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PLSM calculated?
We run Pulsenmore Ltd. Ordinary Shares through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $3.20, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Pulsenmore Ltd. Ordinary Shares currently trades 31 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Pulsenmore Ltd. (PLSM)?
The closing price on Sep 23, 2026 was $2.44. Our model-based fair value is $3.20, about +31% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Pulsenmore Ltd. Ordinary Shares right now?
The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($2.11 to $4.00) leaves room in how you read the outcome.

Key figures of Pulsenmore Ltd. Ordinary Shares

How large is the market capitalisation of Pulsenmore Ltd. (PLSM)?
The market capitalisation of Pulsenmore Ltd. Ordinary Shares is $15.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Pulsenmore Ltd. (PLSM)?
Earnings per share at Pulsenmore Ltd. Ordinary Shares are $−0.8400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Pulsenmore Ltd. (PLSM)?
The net margin of Pulsenmore Ltd. Ordinary Shares is −39.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Pulsenmore Ltd. (PLSM)?
The return on equity (ROE) of Pulsenmore Ltd. Ordinary Shares is −17.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Pulsenmore Ltd. (PLSM)?
On an EBIT basis the return on assets of Pulsenmore Ltd. Ordinary Shares is −21.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How fast is revenue growing at Pulsenmore Ltd. (PLSM)?
Revenue at Pulsenmore Ltd. Ordinary Shares is growing +578% versus a year earlier (3y avg +55.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Pulsenmore Ltd. (PLSM) generate?
The free cash flow of Pulsenmore Ltd. Ordinary Shares is −33.0M ILS (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Pulsenmore Ltd. (PLSM) hold?
Pulsenmore Ltd. Ordinary Shares holds more cash than debt, 20.0M ILS net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Pulsenmore Ltd. Ordinary Shares in the live analysis

One click puts Pulsenmore Ltd. Ordinary Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.